Clinical trial · Interventional
Ultra Sound Guided Fine Needle Aspiration Cytology (FNAC) of Liver and Pancreas Tumours
NCT00991601CI-TRIAL-00004019suspendedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): New ultra sound technology have made this present study design less relevant and force us to change the design of the study.
Summary
Brief summary (as posted)
Patients with tumors in liver or pancreas are randomized to ultrasound (UL)-guided FNAC biopsies with guidance method or UL-guided FNAC biopsies with free-hand method.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Tumors in Liver | — | UNRESOLVED | — |
| Tumors in Pancreas | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| FNAC (fine needle aspiration cytology) | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- biopsy arm
- description
- patients with tumors in liver and/or pancreas
- interventionNames
- Procedure: FNAC (fine needle aspiration cytology)
Primary outcomes (1)
- measure
- quality of obtained biopsy
- timeFrame
- one year
Secondary outcomes (1)
- measure
- patients pain and discomfort at procedure
- timeFrame
- immediately
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * adult over 18 years * tumors in liver and/or pancreas Exclusion Criteria: * low coagulation factors * mentally ill patients.
References
Publications (0)
Data not yet available
No reference posted for this study.